Apixaban Versus Rivaroxaban in Non Valvular Atrial Fibrillation

NCT06862726 · clinicaltrials.gov ↗

PHASE4

Phase

ENROLLING_BY_INVITATION

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Valvular Atrial Fibrillation

Interventions

DRUG: Anti Xa dosage
DRUG: Dosage of PT-INR

Sponsor

Les Laboratoires des Médicaments Stériles